Holen Sie sich die Stockscreener-App
22.98
0.79%
0.18
Handel nachbörslich:
22.98
Überblick
Nachrichten
Preisverlauf
Optionskette
Warum fällt PHG?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$22.80
Offen:
$22.96
24-Stunden-Volumen:
1.51M
Relative Volume:
1.46
Marktkapitalisierung:
$21.60B
Einnahmen:
$19.49B
Nettoeinkommen (Verlust:
$-757.52M
KGV:
-29.14
EPS:
-0.7885
Netto-Cashflow:
-
1W Leistung:
+0.22%
1M Leistung:
-10.20%
6M Leistung:
-12.56%
1J Leistung:
-13.35%
1-Tages-Spanne:
$22.93
$23.12
1-Wochen-Bereich:
$22.46
$23.12
52-Wochen-Spanne:
$21.48
$32.91
Koninklijke Philips N V Adr Stock (PHG) Company Profile
Firmenname
Koninklijke Philips N V Adr
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie PHG mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PHG
Koninklijke Philips N V Adr
|
22.98 | 21.21B | 19.49B | -757.52M | 0 | -0.7885 |
|
ABT
Abbott Laboratories
|
132.96 | 229.69B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.43 | 154.62B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
382.55 | 145.37B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
85.60 | 104.14B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.85 | 44.97B | 5.54B | 4.18B | 623.10M | 7.00 |
Koninklijke Philips N V Adr Stock (PHG) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-25 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
| 2025-02-20 | Hochstufung | UBS | Neutral → Buy |
| 2024-10-29 | Hochstufung | Jefferies | Underperform → Hold |
| 2024-05-13 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2024-05-07 | Hochstufung | Exane BNP Paribas | Underperform → Neutral |
| 2024-04-30 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2024-04-30 | Hochstufung | UBS | Sell → Neutral |
| 2024-02-07 | Herabstufung | Exane BNP Paribas | Outperform → Underperform |
| 2023-07-12 | Eingeleitet | Goldman | Buy |
| 2023-01-17 | Herabstufung | UBS | Neutral → Sell |
| 2022-10-18 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-10-14 | Herabstufung | Deutsche Bank | Hold → Sell |
| 2022-09-12 | Hochstufung | Societe Generale | Hold → Buy |
| 2022-09-06 | Hochstufung | UBS | Sell → Neutral |
| 2022-07-25 | Herabstufung | Societe Generale | Buy → Hold |
| 2022-06-16 | Herabstufung | UBS | Neutral → Sell |
| 2022-01-20 | Herabstufung | Jefferies | Buy → Hold |
| 2022-01-14 | Hochstufung | HSBC Securities | Hold → Buy |
| 2022-01-12 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-09-08 | Eingeleitet | Jefferies | Buy |
| 2021-07-08 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2021-06-21 | Herabstufung | HSBC Securities | Buy → Hold |
| 2021-03-18 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-07-28 | Eingeleitet | Societe Generale | Buy |
| 2019-07-30 | Eingeleitet | Citigroup | Buy |
| 2018-02-12 | Hochstufung | Berenberg | Hold → Buy |
| 2017-11-09 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2017-10-16 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2017-06-21 | Herabstufung | Natixis Bleichroeder | Buy → Neutral |
| 2017-04-25 | Herabstufung | Societe Generale | Buy → Hold |
| 2016-12-12 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2016-11-23 | Eingeleitet | Citigroup | Buy |
| 2016-05-11 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
| 2016-03-01 | Hochstufung | HSBC Securities | Reduce → Hold |
| 2016-02-16 | Herabstufung | Jefferies | Hold → Underperform |
| 2015-11-27 | Eingeleitet | ING Group | Hold |
| 2015-09-08 | Eingeleitet | Credit Suisse | Outperform |
| 2015-08-27 | Hochstufung | Nomura | Neutral → Buy |
| 2015-07-28 | Hochstufung | Societe Generale | Hold → Buy |
| 2011-01-25 | Herabstufung | HSBC Securities | Overweight → Neutral |
| 2009-12-07 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2009-10-16 | Hochstufung | HSBC Securities | Neutral → Overweight |
| 2009-05-08 | Herabstufung | UBS | Buy → Neutral |
Alle ansehen
Koninklijke Philips N V Adr Aktie (PHG) Neueste Nachrichten
Global AI in Remote Patient Monitoring Market to Cross USD 13 Billion by 2032 | DelveInsight - GlobeNewswire Inc.
Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace
Sony Group Corp. ADR rises Wednesday, still underperforms market - MarketWatch
CBRE Group Inc (CBRE) Stock: A Closer Look at the Market Potential - News Heater
Sony Group Corp. ADR outperforms competitors despite losses on the day - MarketWatch
Taiwan Air Treatment Systems Industry Report: From AIoT to Wearables - GlobeNewswire Inc.
Sony Group Corp. ADR rises Wednesday, outperforms market - MarketWatch
Selling Your Koninklijke Philips N.V. ADR (PHG) Stock? Here’s What You Need To Know - Stocks Register
Data-Based Insights About Koninklijke Philips N.V. ADR (PHG) - Stocks Register
Koninklijke Philips N.V. ADR (PHG) Shares Up Despite Recent Market Volatility - The News Heater
P3 Health Partners Inc (PIII) Stock: Evaluating the Annual Growth - The News Heater
Nabors Industries Ltd (NBR) Stock: A SWOT Analysis - The News Heater
Sun Country Airlines Holdings Inc (SNCY) Stock: A Value Analysis - The News Heater
Sony Group Corp. ADR outperforms market on strong trading day - MarketWatch
Weekly Upgrades and Downgrades - InvestorPlace
Europe Cancer Diagnostics Market Size & Outlook, 2024-2030 - Grand View Research
Sony Group Corp. ADR outperforms competitors on strong trading day - MarketWatch
Philips has another Class I level ventilator recall - Mass Device
PHG vs. ESLOY: Which Stock Is the Better Value Option? - Yahoo Finance
China Operating Room Equipment Market Size & Outlook, 2030 - Grand View Research
New 4-Star Stocks - Morningstar
Philips to repurchase shares for up to $137.4M - Mass Device
Philips inks new multi-year patient monitoring collab - Mass Device
Philips wins FDA clearance for next-gen digital pathology system - Mass Device
GE HealthCare: Initiating Coverage With Wide Moat, Shares Look Attractive - Morningstar
Philips unveils new AI-powered cardiovascular ultrasound - Mass Device
Philips prices $758.6M offering, expands access to intracardiac echocardiography - Mass Device
Philips has positive AI-powered cardiac monitoring data - Mass Device
Philips announces exchange ratio for 2023 dividend - Philips
Philips Stock Books Record Gain After U.S. Ventilator Settlement - WSJ
Philips creates 'clear path forward' with FDA over Respironics probe - Sharecast.com
Philips taps Stryker controller as next CFO - Mass Device
Philips unveils radiation-free imaging tech that uses light instead of X-ray - Mass Device
Philips unveils next-gen ultrasound systems - Mass Device
Finanzdaten der Koninklijke Philips N V Adr-Aktie (PHG)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.25%
0.52%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):